NEW YORK (GenomeWeb News) – Complete Genomics said today that it has raised $45 million from new and previous investors, and it will use the funds to build up its Silicon Valley genome sequencing facility.

The Series D financing included two new investors, Essex Woodlands Health Ventures and OrbiMed Advisors, as well as investments from Enterprise Partners Venture Capital, OVP Venture Partners, Prospect Venture Partners, and Highland Capital Management.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.